Cover Image
市場調查報告書

全球過敏原免疫療法市場 2019年∼2023年

Global Allergy Immunotherapies Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 362098
出版日期 內容資訊 英文 113 Pages
訂單完成後即時交付
價格
Back to Top
全球過敏原免疫療法市場 2019年∼2023年 Global Allergy Immunotherapies Market 2019-2023
出版日期: 2018年11月13日 內容資訊: 英文 113 Pages
簡介

過敏原免疫療法市場相關資料

開發新藥技術的進步,及全球性過敏的增加,成為過敏風險的香煙等產品的普及等,促進過敏原免疫療法市場成長。Technavio的分析師預測,過敏原免疫療法市場到2023年將以超越7%的年複合成長率成長。

本報告提供全球過敏原免疫療法市場調查,市場概要,各產品、各地區的市場規模的變化與預測,市場成長要素及課題分析,開發平台,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模的變化與預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形
  • 開發平台

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 市場比較:各產品
  • 皮下免疫療法(SCIT)
  • 舌下免疫療法(SLIT)
  • 市場機會:各產品

第7章 客戶形勢

第8章 地區形勢

  • 市場區隔:各地區
  • 市場比較:各地區
  • 歐洲、中東、非洲
  • 南北美洲
  • 亞太地區
  • 市場牽引國
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭模式

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer

第14章 附錄

  • 調查方法
  • 簡稱的清單

第15章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR30261

About this market

The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Technavio's analysts have predicted that the allergy immunotherapies market will register a CAGR of more than 7% by 2023.

Market Overview

Increasing prevalence of various types of allergies

The increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.

Unknown pathogenesis

The Unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.

For the detailed list of factors that will drive and challenge the growth of the allergy immunotherapies market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be concentrated and with the presence of few companies including ALK and Allergy Therapeutics the competitive environment is quite intense. Factors such as the emerging drug development technologies and the technological advances in allergy diagnostics, will provide considerable growth opportunities to allergy immunotherapies manufactures. ALK, Allergy Therapeutics, Stallergenes Greer, HAL Allergy, and Merck are some of the major companies covered in this report.

'With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors.'

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
  • A. PIPELINE

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • SCIT - Market size and forecast 2018-2023
  • SLIT - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • EMEA - Market size and forecast 2018-2023
  • Americas - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global immunology treatment market
  • Exhibit 02: Segments of global immunology treatment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global allergy immunotherapies market: Overview
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Global allergy immunotherapies market pipeline: Overview
  • Exhibit 19: Global allergy immunotherapies market pipeline: Overview
  • Exhibit 20: Product - Market share 2018-2023 (%)
  • Exhibit 21: Comparison by product
  • Exhibit 22: SCIT - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: SCIT - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Opportunity analysis of global SCIT market
  • Exhibit 25: SLIT - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: SLIT - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Opportunity analysis of global SLIT market
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Market share by geography 2018-2023 (%)
  • Exhibit 31: Geographic comparison
  • Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Geographical presence of few prominent vendors 2018
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: ALK - Vendor overview
  • Exhibit 48: ALK - Business segments
  • Exhibit 49: ALK - Organizational developments
  • Exhibit 50: ALK - Geographic focus
  • Exhibit 51: ALK - Key offerings
  • Exhibit 52: ALK - Key customers
  • Exhibit 53: Allergy Therapeutics - Vendor overview
  • Exhibit 54: Allergy Therapeutics - Business segments
  • Exhibit 55: Allergy Therapeutics - Organizational developments
  • Exhibit 56: Allergy Therapeutics - Segment focus
  • Exhibit 57: Allergy Therapeutics - Key offerings
  • Exhibit 58: Allergy Therapeutics - Key customers
  • Exhibit 59: HAL Allergy - Vendor overview
  • Exhibit 60: HAL Allergy - Business segments
  • Exhibit 61: HAL Allergy - Organizational developments
  • Exhibit 62: HAL Allergy - Key offerings
  • Exhibit 63: HAL Allergy - Key customers
  • Exhibit 64: Merck - Vendor overview
  • Exhibit 65: Merck - Business segments
  • Exhibit 66: Merck - Organizational developments
  • Exhibit 67: Merck - Geographic focus
  • Exhibit 68: Merck - Segment focus
  • Exhibit 69: Merck - Key offerings
  • Exhibit 70: Merck - Key customers
  • Exhibit 71: Stallergenes Greer - Vendor overview
  • Exhibit 72: Stallergenes Greer - Business segments
  • Exhibit 73: Stallergenes Greer - Organizational developments
  • Exhibit 74: Stallergenes Greer - Geographic focus
  • Exhibit 75: Stallergenes Greer - Key offerings
  • Exhibit 76: Stallergenes Greer - Key customers
Back to Top